Navigation Links
Prostate cancer study tracks long-term urinary, sexual and bowel function side effects
Date:1/30/2013

A new study comparing outcomes among prostate cancer patients treated with surgery versus radiotherapy found differences in urinary, bowel and sexual function after short-term follow-up, but those differences were no longer significant 15 years after initial treatment.

The study, led by first author Matthew Resnick, M.D., instructor in Urologic Surgery, Vanderbilt University Medical Center, was published in the Jan. 31 issue of the New England Journal of Medicine.

From Oct. 1, 1994, through Oct. 31, 1995, investigators enrolled men who had been diagnosed with localized prostate cancer in the Prostate Cancer Outcomes Study (PCOS).

For the current study, investigators followed 1,655 men between the ages of 55 and 74 from the PCOS group, of whom 1,164 (70.3 percent) had undergone prostatectomy, while 491 (29.7 percent) had undergone radiotherapy. At the time of enrollment, the patients were asked to complete a survey about clinical and demographic issues and health-related quality of life. The men were contacted again at set times following treatment and were asked about clinical outcomes and disease-specific quality of life issues.

Men whose prostates had been surgically removed were significantly more likely than those who received radiation therapy to report urinary leakage at two years and five years. However, at 15 years, the investigators found no significant difference in the adjusted odds of urinary incontinence. Nonetheless, patients in the surgery group were more likely to wear incontinence pads throughout the 15-year follow-up period.

Men in the prostatectomy group were also significantly more likely than those in the radiotherapy group to report having problems with erectile dysfunction two years and five years after surgery.

"At the two- and five-year time points, men who underwent prostatectomy were more likely to suffer from urinary incontinence and erectile dysfunction than men who re
'/>"/>

Contact: Dagny Stuart
dagny.stuart@vanderbilt.edu
615-936-7245
Vanderbilt University Medical Center
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. New drug prevents spread of human prostate cancer cells
2. 2 genetic deletions in human genome linked to the development of aggressive prostate cancer
3. Intensity Modulated Radiation Therapy optimal for localized prostate cancer
4. Study examines adverse effects among different radiation therapies for prostate cancer
5. Study Casts Doubt on Value of Pricey Prostate Cancer Therapy
6. Warren Buffett Has Early Stage Prostate Cancer
7. Genetic abnormalities in benign or malignant tissues predict relapse of prostate cancer
8. PSA screening to detect prostate cancer can be beneficial to younger and at-risk men
9. Mayo Clinic researchers discover biomarkers for prostate cancer detection, recurrence
10. Quality of care, other issues may cause worse results in black prostate cancer surgery patients
11. Higher hospital volume more important than surgeon experience in outcome of prostate cancer surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... HealthEconomics.Com , the global leader ... present a new breakthrough in digital marketing and communications ... the reach of traditional, real-world trade shows and conferences ... feel, and benefits of a physical trade show, but ... hours a day, seven days a week, and three ...
(Date:5/20/2013)... that improved health care and significant reductions in drug ... relationship between physicians and drug company representatives who promote ... , This system, which has been in place for ... up to date on new medications, and always provided ... on the newest drugs, as well as other supplies ...
(Date:5/20/2013)... Las Vegas, NV (PRWEB) May 20, 2013 ... Health IT to improve the exchange of healthcare information, ... the creation of the WEDI ICD-10 State Collaborative ... organizations and their members in order to increase efficiencies ... ICD-10 compliance. , The goal of the new initiative ...
(Date:5/20/2013)... Irving, Texas (PRWEB) May 20, 2013 ... and Phytel, the leader in automated, provider-led population ... health systems to effect change and successfully pursue ... of advisory services and technology to accelerate the ... of the VHA IMPERATIVTM performance improvement suite of ...
(Date:5/20/2013)... May 20, 2013 The Multiple System ... the launch of its new Multiple System Atrophy ... few years, The MSA Coalition’s grass roots fundraising has ... mission beyond patient/caregiver support to now include education, advocacy ... all donations received by The Coalition go directly into ...
Breaking Medicine News(10 mins):Health News:HealthEconomics.Com Launches HE-Xpo, an Online Virtual Trade Show, Educational Center and Exhibit Hall at Major Pharmaceutical Industry Meeting 2Health News:HealthEconomics.Com Launches HE-Xpo, an Online Virtual Trade Show, Educational Center and Exhibit Hall at Major Pharmaceutical Industry Meeting 3Health News:Breakup of physician, drug company relationship could improve health care, cut cost 2Health News:Breakup of physician, drug company relationship could improve health care, cut cost 3Health News:WEDI Launches New ICD-10 State Collaborative Initiative to Increase Efficiencies and Reduce Compliance Time and Costs 2Health News:VHA Partners with Phytel to Add Population Health Management Services to the VHA IMPERATIVTM Performance Improvement Suite of Offerings 2Health News:VHA Partners with Phytel to Add Population Health Management Services to the VHA IMPERATIVTM Performance Improvement Suite of Offerings 3Health News:VHA Partners with Phytel to Add Population Health Management Services to the VHA IMPERATIVTM Performance Improvement Suite of Offerings 4Health News:Multiple System Atrophy (MSA) Research Grant Program Announced 2Health News:Multiple System Atrophy (MSA) Research Grant Program Announced 3Health News:Multiple System Atrophy (MSA) Research Grant Program Announced 4Health News:Multiple System Atrophy (MSA) Research Grant Program Announced 5
... ... New book - ,Public Health 101, - by Richard K. Riegelman, ... for an undergraduate course by the same name. The book is an ... that view an understanding of public health issues as a critical component ...
... Aug. 1 issue of the journal SLEEP indicates ... apnea (OSA) if they have at least one sibling who ... that after accounting for socioeconomic status, age, and geographic region, ... a standardized incidence ratio of 33.2 in boys and 40.5 ...
... WASHINGTON, July 31 Pharmaceutical Research and Manufacturers of America ... after the Energy and Commerce Committee mark-up of the House ... to working with the Administration and Congress to help enact ... with the White House and the Senate Finance Committee, which ...
... WASHINGTON, July 31 Speaker Nancy Pelosi issued the ... Commerce Committee to pass the America,s Affordable Health Choices Act, the ... House Ways and Means Committee and Education and Labor Committee approved ... "For more than 60 years, we have tried as a nation ...
... , WASHINGTON, July 31 ... "The Importance of a Cost Control Enforcement Entity In ... President Obama,s proposed Independent Medicare Advisory Council (IMAC). The ... experts who would routinely review Medicare spending and provide ...
... Survivors of the childhood cancer neuroblastoma are eight times ... to be married, and more likely to have lower ... online July 31 in the Journal of the ... because minimal information exists on the long-term outcomes for ...
Cached Medicine News:Health News:New Book by Leading Authority Responds to National Initiative to Bring Undergraduate Public Health Education to All American Colleges and Universities 2Health News:New Book by Leading Authority Responds to National Initiative to Bring Undergraduate Public Health Education to All American Colleges and Universities 3Health News: Study finds increased 'sibling risk' of obstructive sleep apnea in children 2Health News:House Tri-Committee Bill Would Hurt Patients and Kill Jobs 2Health News:House Tri-Committee Bill Would Hurt Patients and Kill Jobs 3Health News:Concord Coalition Releases Issue Brief on Administration's IMAC Proposal 2Health News:Long-term health and social outcomes for neuroblastoma survivors 2
(Date:5/20/2013)... , Kalifornien, 20. Mai 2013 ... das Unternehmen die CE-Kennzeichnung für die SL-Produktfamilie ... von Aneurysmen erhalten hat. Das Unternehmen hat ... mit der kontrollierten Einführung dieser neuen Modelle ... SL-Produktfamilie auch ein verbessertes Handling, das es ...
(Date:5/20/2013)... DIEGO , May 20, 2013 Enrollment ... Elcelyx Therapeutics, Phase 2b dose-finding clinical trial of product ... metformin, the foundational treatment for Type 2 diabetes. Elcelyx ... multicenter U.S. program in June. Results of the trial,s ... expected in late summer, and the read-out for long-term ...
(Date:5/20/2013)... , May 20, 2013  AbbVie (NYSE: ... of a Phase 3 clinical study called SONAR ... the effects of the investigational compound atrasentan - when ... kidney disease in patients with stage 2 to ... diabetes.  SONAR is a large, multinational, double-blind, placebo-controlled ...
Breaking Medicine Technology:Sequent Medical, Inc. bringt neue SL-Produktfamilie seiner WEB Geräte zur Embolisation von Aneurysmen auf den Markt 2Sequent Medical, Inc. bringt neue SL-Produktfamilie seiner WEB Geräte zur Embolisation von Aneurysmen auf den Markt 3Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 2Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 3Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 4AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 2AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 3AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 4AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 5AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 6
... NATICK, Mass., Jan. 4, 2011 Boston Scientific Corporation ... of its acquisition of Sadra Medical, Inc. of Los ... announced on November 19, 2010.  Under the terms of ... the remaining 86 percent of Sadra Medical,s equity not ...
... and Company) (NYSE: BDX ), a leading global medical ... Annual J. P. Morgan Healthcare Conference on Monday, January 10, 2011, ... BD,s presentation can be accessed from the BD corporate website at ... January 17, 2011.   About BDBD is ...
Cached Medicine Technology:Boston Scientific Completes Acquisition of Sadra Medical 2Boston Scientific Completes Acquisition of Sadra Medical 3Boston Scientific Completes Acquisition of Sadra Medical 4
... Autotransfusion System processes blood collected from ... red blood cells for return to ... This is achieved with only one ... bowl design, coupled with sophisticated software, ...
The Wixson Hip Positioner is used for stable positioning of a patient during total hip and revision surgery. It is designed to be placed on top of the operating table....
Stryker Instruments InterPulse System advances the ease and performance of battery powered irrigation for Orthopaedics, Trauma, and Wound Care....
... VersaNail System is a complete system of ... use with TTC fusion surgery. The system ... and integrates clinical research and engineering with ... every patient is different, and because the ...
Medicine Products: